A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis
Titel:
A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis
Auteur:
Yu, Chen Zhang, Furen Ding, Yangfeng Li, Yumei Zhao, Yi Gu, Jun Guo, Shuping Pan, Weili Jin, Hongzhong Sun, Qing Kang, Xiaojing Yang, Qinping Jiang, Xian Song, Zhiqiang Lu, Qianjin Pang, Xiaowen Kuang, Yehong Deng, Danqi Li, Yuzhen Zhang, Chunlei Tao, Juan Xie, Liangzhi Wang, Yan Wang, Jieying Wang, Gang